Company news

OncoSil Medical Ltd news in 2025

OncoSil Medical Ltd's news releases, calls and decks from 2025, newest first.

View company

OSPREY Analysis Shows Survival Benefit for OncoSil Patients

December 2, 2025

Response to ASX Aware Letter

September 29, 2025

Positive Preliminary Results from PANCOSIL Phase 1-2 Study

September 17, 2025

Appendix 4E and Annual Report

August 29, 2025

Completion of Recruitment in TRIPP-FFX Clinical Trial

July 22, 2025

Completion of Recruitment in PANCOSIL Study

July 3, 2025

OSL announces $8.7m capital raise to drive commercialisation

May 26, 2025

Consolidation/Split - OSL

May 1, 2025

120 German Hospitals entitled to negotiate fee for OncoSil

February 3, 2025

OncoSil Medical Receives MDR Approval

January 27, 2025

OncoSil receives $1.05m R&D tax incentive

January 8, 2025

Decks in 2025